Egyptian Liver Journal

Table 5 Response and recurrence in different AFP levels in the studied patients

From: Risk stratification of patients with hepatocellular carcinoma undergoing trans arterial chemoembolization using an alpha-fetoprotein model

		TACE n = 132
		AFP level < 100 IU/mL	AFP level 100–1000 IU/mL	AFP level > 1000 IU/mL
		n = 79	n = 34	n = 19
Response	Complete response	67 (84.8%)	25 (73.5%)	15 (78.9%)
	Partial response	9 (11.4%)	9 (26.5%)	3 (15.8%)
	Stationary disease	2 (2.5%)	0 (0.0%)	0 (0.0%)
	Progressive disease	1 (1.3%)	0 (0.0%)	1 (5.3%)
Recurrence	No recurrence	18 (26.9%)	4 (16.0%)	5 (33.3%)
Recurrence	Recurrence	49 (73.1%)	21 (84.0%)	10 (66.7%)

Back to article page